← Back to headlines
AstraZeneca Considers Merger with Bristol Myers Squibb
Rumors suggest British pharmaceutical giant AstraZeneca might pursue a merger with American competitor Bristol Myers Squibb, prompting commentary that such large-scale fusions often lead to failure.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
